Recently, the aesthetics industry has seen a familiar but costly scenario: A product marketed for years as suitable for mesotherapy (injection) was suddenly “clarified” by its local distributor—in writing—to be for topical cosmetic use only, as per its regulatory dossier.
From a consulting perspective, this exposes a structural risk many foreign manufacturers underestimate—the loss of regulatory control once licensing and market execution are fully delegated to a distributor.
When distributors:
❌ Push marketing beyond approved indications
❌ Allow off‑label use without transparency
❌ Rely on perception instead of documentation
Short‑term sales may rise—but brand trust quietly erodes. In the market’s eyes, your distributor’s message is your brand’s voice.
“Hands‑off licensing” reduces initial complexity but severely weakens risk control. Disclaimers may protect distributors—brand damage cannot be disclaimed.
That’s why leading manufacturers now:
❎ Hold licenses directly, or
❎ Appoint independent regulatory consultants as license holders
Distributors sell products.
Regulatory control protects brands.